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PP-115 Antiviral drug response among patients of
Hepatitis-B co-infected with Hepatitis-D virus
T. Hussain1, T. Sosorburam2, A. Samdan3, P. Deo4 *,
A. Seid Adji5, A. Hayat6. 1Department of Internal Medicine
and Cardiology, Union Hospital, Tongji Medical College,
Huazhong University of Sciences and Technology, Wuhan,
430030, China, 2Department of Anesthesia, Tongji Hospital,
Tongji Medical College, Huazhong University of Sciences
and Technology, Wuhan, 430030, China, 3Department of
Anesthesia and Intensive care unit, University Center
Hospital, Ulanbator, Mongolia, 4Department of Laboratory
Medicine, Union Hospital, Tongji Medical College,
Huazhong University of Sciences and Technology, Wuhan,
430030, China, 5Department of Internal Medicine and
Gastroenterology, Union Hospital, Tongji Medical College,
Huazhong University of Sciences and Technology, Wuhan,
430030, China, 6Department of Pathology and Microbiology,
Rawalpindi Medical College Allied Hospitals, Rawalpindi,
46000, Pakistan
Background: Since Hepatitis-B patients coinfected/
superinfected with Hepatitis-D virus are increasing in South-
East Asian countries like Pakistan and India, so the study
was designed to observe the effects of antiviral drugs like
lamivudine on sero-conversion of HBeAg positive cases.
Methods: This study was conducted at Hepatology clinic,
Lahore Pakistan, over a period of 2 years from 2007 to
2009. A total of 97 ELISA conﬁrmed Hepatitis-B positive
patients with deranged liver functions for 6 months were
recruited. All were screened for HBeAg, HBV-DNA and anti-
HDV using ELISA test. They were subdivided in 2 groups.
GroupA included patients who were HBeAg and HBV-DNA
positive but Anti-HDV negative, while group B comprised
of patients positive for HBeAg, HBV-DNA and Anti-HDV (all
positive). Reverse transcriptase inhibitor (RTI), lamivudine
in a dose of 100mg/day was given to all till sero-conversion.
Results: Out of total 97 patients 64% (n = 62) were males,
mean age 56±4 years. 55 cases were in group A and 42
were in group B. At the beginning of study, mean HBeAg was
284±179 in group A and 137±151 in group B. Within a period
of 6 months, ALT became normal in 70% patients (n = 38)
among group A, and 19% (n = 8) among group B. Serum viral
markers did not change much till 1 year of treatment and
was signiﬁcantly slower among group B. 34% (n = 19) patients
in group A and 12% (n = 5) patients in group B sero-converted
completely at the end of 2 years therapy.
Conclusions: Hepatitis-B patients co-infected with
Hepatitis-D virus have a chance of seroconversion and still
the effective therapy options are available to treat such
scenario.
Effort should be maximized to catch the diagnosis earlier
and start the therapy in an optimal mode so as to get
enhanced beneﬁts of antiviral drugs like lamivudine.
PP-116 Comparison of HBVDNA results detected by 5
HBV/HCV/HIV-1 blood screening kits
X. Wu1, C. Zhou1, W.-J. Gu1, H.-Y. Lan1, Z.-L. Liang1 *.
1NICPBP, Beijing, China
Background: Public demand for higher standards of
screening for infections agents in transfusion products has
fueled the development and advancement of nucleic acid
test technology. This report describes a comparation of the
HBV NAT screening results by 1 foreign and 4 domestic
HBV/HCV/HIV-1 NAT screening kits.
Method: 1 foreign and 4 domestic HBV/HCV/HIV-1 NAT
screening kits were applied to detect 393 plasma samples
from chronic hepatitis B patients and healthy people and
an additional plasma for sensitivity, These results were
compared with the result of Roche COBAS TaqMan HBV Test
for quantitation of HBVDNA in serum. In addition, results of
HBsAg by Architect and HBVDNA by screening kits were also
compared.
Results: 325 positive results and 69 negative results were
found in 394 samples by reagent II. 216 311 positive results
were found in the 325 positve samples and 38 69 negative
results were detected in the 69 negative samples by 5
screening kits; The lowest concentration of HBVDNA by the
foreign NAT kit and A/B/C domastic kit were 6 IU/mL and 50
IU/mL, respectively. The domestic kit D had false-positive
results. In addition, 285 positive results and 109 negative
results of HBsAg were detected in 394 samples by Artichtect
HBsAg. 212 282 positive results for HBVDNA were found in
the 285 positve samples for HBsAg and 49 105 negative
results for HBVDNA were found in 109 negative samples
for HBsAg by 5 screening kits. Most of the different results
came from the sera with HBVDNA concentration lower than
100 IU/mL.
Conclusions: Domastic reagents of HBV/HCV/HIV-1 for
HBVDNA have lower sensitivity than foreign reagent. Further
studies shall be concentrat on the accuracy of both foreign
and domestic NAT reagents.
PP-117 General practitioners and hepatitis B: a survey
to determine current level of awareness and
treatment capabilities of chronic hepatitis B
M.M. Tian1, X.L. Fan1 *, Y.R. Li1, X.F. Duan1. 1Beijing Ditan
Hospital, China
Background and Objectives: In order to play the role of
general practitioners in prevention and treatment of chronic
hepatitis B better, we investigated the current level of the
awareness and treatment capabilities of chronic hepatitis B
among the general practitioners.
Methods: A written examination survey was conducted to
102 general practitioners in a district of Beijing. They came
from 40 regional community health service centers, 2 or 3
doctors per center.
Results: The survey revealed that 58.8% of general
practitioners knew the basic diagnostic points, and 91.2%
were aware of the control of disease prevention. Whereas,
only 56.8% of the surveyed doctors were aware of the
severity of the disease and could make a correct assessment
of prognosis of the disease. Only 27.5% had the antivirus
therapy concept. Only 19.6% knew the common side effects
of interferon, and 6.9% knew the types of antiviral drugs
and were sure of which agent to use.
Conclusion: To facilitate the hepatitis B patients to be
better managed in both of the specialty hospitals and
the community, improving the level of the awareness and
practice of chronic hepatitis B management in general
practitioner community seems warranted and professional
knowledge training is necessary.
The research was supported by the major science and
technology project foundation of the national eleventh ﬁve-
year plan (No. 2009ZX10004-903).
PP-118 Effect of hepatitis B virus X protein on function
of natural killer cell in NK-92 cells
Y.X. Liu1 *, L.N. Liu2, X. Zhang1, B.P. Zhou1. 1Shenzhen
Third People’s Hospital, Afﬁliated Hospital of Guangdong
Medical College, 2Chuanshan College of University of South
China, China
Background: Many viruses have evolved strategies to
modulate the activity of NK cells in response to the selective
pressure exerted by NK cells, such as envelope protein E2
of HCV, UL16 of HCMV, et al. Whether Hepatitis B virus
can produce any protein that can modulate the activity
of NK cells is not clear. Here in the present research, we
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investigate the inﬂuence of the hepatitis B virus X protein
on function of natural killer (NK) cell in NK-92 cells.
Methods: The recombinant eukaryotic expression plasmid
pcDNA3.1 (+)-HBX was transfected into NK-92 cells with
lipofectamine. The expression of HBV X gene was detected
by RT-PCR and Western blotting. Western blotting was also
applied for the determination of NKG2D level in NK-92 cells.
ELISA was employed to determine the IFN-g level secreted
by NK-92 cells. And ﬁnally the cytotoxicities of NK cells were
analyzed by MTT colorimetry, with the hepatoblastoma cell
line (HepG2) as target cell.
Results: RT-PCR and western blotting conﬁrmed the
expression of HBV X gene in the NK-92 cells transfected with
pcDNA3.1(+)-HBX. Compare to empty vector transfected and
untransfected cells, NKG2D level signiﬁcantly decreased,
cytotoxicity function and IFN-g secretion markedly
attenuated in NK-92 cells transfected with cDNA3.1(+)-
HBX.
Conclusions: Transient expression of HBV X gene can
decrease IFN-g secretion and cytotoxicities of NK-92 cells.
The inﬂuence of the hepatitis B virus X protein on
cytotoxicities of NK cell was probably associated with
downregulation of expression of NKG2D.
PP-119 Lamivudine in hepatitis B reactivation in
patients with rheumatologic diseases on chronic
immunosuppression
M.E. Velasquez1, A. Salvana1, E. Tripon1, E.L. Ang1,
N. Estanislao IV1, H. Flores1, V. Banez1, J. Ong1.
1University of the Philippines Philippine General Hospital,
Philippines
Introduction/Objectives: Chronic immunosuppression is a
mainstay of treatment for rheumatologic diseases, but has
been associated with hepatitis B reactivation. This review
focused on the effectiveness of lamivudine as prophylaxis or
treatment of hepatitis B reactivation among patients with
rheumatologic diseases on chronic immunosuppression.
Methods: A search of Medline, Pubmed and Cochrane
databases was performed which yielded 18 studies
including 4 observational cohort studies (1 prospective,
3 retrospective). Case reports and reviews were excluded.
Authors were contacted to get fulltext articles.
Results: Forty-four rheumatologic patients on prednisolone
alone or in combination with DMARDS or biologics,
received lamivudine 100mg/day as treatment (n = 22) for
reactivation or as prophylaxis (n = 22). One study included
5 Lupus Nephritis patients while the 3 studies included
patients with Rheumatoid Arthritis (n = 14), Systemic
Lupus Erythematosus (n = 6), Ankylosing Spondylitis (n = 4),
Polymyalgia Rheumatica (n = 5), Psoriatic Arthritis (n = 3) and
1 patient each with Systemic Sclerosis, Sjogren’s Syndrome,
Dermatomyositis/Polymyositis, Takayasu Arteritis, Henoch-
Schonlein Purpura and Behcet’s syndrome. Elevated levels
of alanine transferase (ALT) at baseline (n = 22) normalized
shortly after lamivudine therapy. HBV-DNA levels were
signiﬁcantly suppressed in 17 patients after treatment. Two
patients developed treatment-resistant YMDD mutation of
HBV and had to be shifted to adefovir. There were no
major adverse events reported and lamivudine treatment
appeared safe and well-tolerated.
Conclusion: Lamivudine as treatment and prophylaxis
for hepatitis B reactivation is a promising strategy in
rheumatologic patients on chronic immunosuppression.
However, the studies are limited by small sample sizes
and heterogeneity, in terms of the type of rheumatologic
disease, type and dosage of immunosuppressive drugs, and
duration of lamivudine treatment. There is a need for
further prospective, preferably RCTs including a larger set
of patients.
PP-120 HBV contamination of medicine instruments in
surgery department
M.M. Attarpour Yazdi1 *. 1Department of Microbiology,
Faculty of Medicine, Shahed University, Tehran, Iran
Objectives: Increase in occurrence of HBV (Hepatitis B
Virus) among the medicine staffs and 3% prevalence
of this infection in Iran and existence of the HBsAg
positive individuals without any special symptom lead to
general consideration about transmission of this infection
by medicine instruments.
Methods: The purpose of this study was evaluation of HBV
contamination in surfaces (such as cabinet and door handles,
telephones, water valves and electrical buttons, . . . ) and
equipments in the surgery department of the Cina hospital
on 2009. Sampling was performed with sterile cotton swabs
in transport medium (BSAS: Bovine Serum Albumin in Sodium
chloride). Samples were tested by PCR technique.
Results: As a result, 43.3% (13 out of 30 samples) of
surfaces and 27.2% (25 out of 92 samples) of equipments
were contaminated before disinfection. 16% (4 out of
25 contaminated samples) of equipments remained
contaminated after disinfections.
Conclusion: There is high contamination percentage in
the surfaces that expresses the necessity of effective and
regulatory disinfection procedures in these sites. According
to the high level of infection in the surfaces and equipments
in the surgery department, these approaches to disinfect
equipments are not sufﬁcient to omit HBV infection.
PP-121 A case control study on the relationship
between IL-6 572, RANTES genetic
polymorphisms and susceptibility to the chronic
hepatitis B among Han adults
F.M. Feng1 *, B.X. Gao1. 1Department of Preventive
Medicine; North China Coal Medical University, China
Objectives: To investigate the association between the
gene polymorphism of IL-6 and RANTES and the outcome
of chronic hepatitis B among in Tangshan area. The
research of genetic polymorphisms improved the understand
of environment-individual susceptibility interaction in
molecular machine and explored the risk factors of
chronic hepatitis B form environmental and the genetic
polymorphisms of IL-6 and RANTES.
Methods: A case control study was adopted in the research,
which included 118 and 61 patients with chronic and acute
hepatitis B (CHB and AHB) virus infection respectively.
PCR-RFLP was used to detect IL-6 and RANTES gene
SNPs ( 597G, 572C of IL-6, and 403G, 28C,In1.1 T of
RANTES). Information on environmental-related risk factors
and pathological changes of tuberculosis was collected using
a pre-tested standard questionnaire. Statistics analysis was
conducted with SPSS for Windows software.
Results: The sex, age, BMI had no differennce in case
and control group. Drinking of man in the CHB was
higher than AHB, the virus-load was also higher in the
group of CHB than AHB. A special serum construction:
the masculine of HBsAg, HBeAg, anti-HBcIgG and PreSAg
at the same time was the hight risk for CHB. But
the high level of ALT, AST, TBIL was the low risk for
CHB. IL-6 572GG genotype occurred more frequently in
the CHB than that in the control (c2 = 8.627, P = 0.003),
with crude ORCG = 2.024, 95%CI: 1.009 4.06; ORGG = 3.367,
95%CI: 1.169 9.709. RANTES In1.1TC genotype occurred
more frequently in the CHB than that in the controls
(c2 = 6.190, P = 0.018), with crude ORTC = 2.278, 95%CI:
1.079 4.808; ORTT = 1.845, 95%CI: 0.770 4.425. There were
no interaction between the gene of IL-6 572 and the index
which include ALT, HBeAg and virus load.
